PHAR$12.463.63%-0.47
Pharming Group Nv Adr (PHAR)
Date: 2026-11-04 16:00O: 12.78H: 13.14L: 12.14C: 12.46Vol: 26.88k
Pharming Group Nv Adr stock is traded at $12.46, with a volume of 26,883. It is down -3.63% in the last 24 hours and up +27.79% over the past month. Pharming Group is a biotechnology company focused on developing and commercializing therapies for rare and ultra-rare diseases, particularly immunological and genetic conditions with high unmet need. It operates as an integrated company with capabilities across clinical development, manufacturing, regulatory affairs, and commercialization, supported by scientific and operational expertise. It leverages its efficient infrastructure to expand its pipeline and improve patient access to treatment. The Company operates in the United States, Europe, and the rest of the world, with the United States contributing the majority of its revenue.
Previous Close:
$12.93
Open:
$12.78
24h Volume:
26,883
Relative Volume:
1.15
Market Cap:
$881.90M
Revenue:
$370.44M
Net Income/Loss:
$12.19M
P/E Ratio:
72.32
EPS:
$0.1723
Net Cash Flow:
$50.74M
1W Performance:
+1.63%
1M Performance:
+27.79%
6M Performance:
-23.98%
1Y Performance:
-5.33%
1-Day Range:
$12.14$13.14
1-Week Range:
$11.75$13.14
52-Week Range:
$9.11$21.34
Pharming Group Nv Adr Stock (PHAR) Company Profile
Market Cap
Revenue
Net Income
Cash Flow
EPS
Pharming Group Nv Adr Stock (PHAR) Upgrades & Downgrades
Pharming Group Nv Adr Stock (PHAR) Financials Data
There is no financial data for Pharming Group Nv Adr (PHAR). Check out other stocks for more information.
